SCHEMBL5134702

SCHEMBL5134702

CCCCN(Cc1ccc(OC)cc1OC)Cc1c(-c2ccccc2)nc(-c2ccccc2)n1CCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
TSHR P16473 3/20 0.42
KDM4E B2RXH2 2/20 0.42
C5AR1 P21730 1/20 0.41
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
CRHR1 P34998 4/20 0.39
POLB P06746 1/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
ATP4A P20648 1/20 0.38
ATP4B P51164 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 1/20 0.37
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5137859 0.97 ALDH1A1 (0.41) ALDH1A1TSHRKDM4EC5AR1BCHE
SCHEMBL5137111 0.96 ALDH1A1 (0.42) ALDH1A1TSHRKDM4EC5AR1BCHE
SCHEMBL5135241 0.94 C5AR1 (0.42) ALDH1A1TSHRKDM4EC5AR1BCHE
SCHEMBL5136562 0.92 ALDH1A1 (0.46) ALDH1A1TSHRKDM4EC5AR1ACHE
SCHEMBL5134872 0.91 C5AR1 (0.44) ALDH1A1TSHRKDM4EC5AR1BCHE
SCHEMBL5135916 0.91 TP53 (0.43) ALDH1A1TSHRKDM4EC5AR1BCHE
SCHEMBL5136649 0.90 LMNA (0.43) ALDH1A1TSHRKDM4EC5AR1CRHR1
SCHEMBL5135642 0.90 C5AR1 (0.42) ALDH1A1TSHRKDM4EC5AR1BCHE
SCHEMBL5069962 0.90 BCHE (0.45) TSHRC5AR1BCHEACHE
SCHEMBL5136939 0.89 CRHR1 (0.42) ALDH1A1TSHRKDM4EC5AR1CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed